Join to View Full Profile
UCSD Moores Cancer Center3855 Health Science Drive, #0987La Jolla, CA 92093
Phone+1 858-822-6185
Fax+1 858-249-0905
Dr. Randall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Michael Randall, MD is an Oncology specialist with a subspecialty in Genitourinary Oncology based in La Jolla, CA. He graduated from the University of Alabama School of Medicine in 2005 and did his fellowship in Hematology and Medical Oncology, and residency in Internal Medicine at the University of California San Diego Medical Center. Currently a Clinical Professor at the University of California, San Diego, Dr. Randall has expertise in prostate cancer, kidney cancer, and bladder cancer. He has published research papers on various oncology topics and has considerable experience in conducting clinical trials. He received the CMS Meaningful Use Stage 1 Certification in 2012-2013.
Education & Training
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2005 - 2008
University of Alabama School of MedicineClass of 2005
Certifications & Licensure
CA State Medical License 2007 - 2026
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
Publications & Presentations
PubMed
- CLO25-100: Improving Germline Testing in At-Risk Patients With Prostate Cancer.Juan Javier-DesLoges, Ana Flores Pimentel, Yu-Wei Chen, Yasoda Satpathy, James Michael Randall
Journal of the National Comprehensive Cancer Network. 2025-03-28 - 6 citationsThe Prognostic Significance of Homologous Recombination Repair Pathway Alterations in Metastatic Hormone Sensitive Prostate Cancer.Aaron M Lee, Ava Saidian, Justin Shaya, Taylor Nonato, Angelo Cabal
Clinical Genitourinary Cancer. 2022-12-01 - 7 citationsGermline alterations among Hispanic men with prostate cancer.Elizabeth Pan, Justin Shaya, Lisa Madlensky, J Michael Randall, Juan Javier-Desloges
Prostate Cancer and Prostatic Diseases. 2022-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
